Skip to main content

Table 5 Outcomes and cost effectiveness

From: Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia

 

No

vaccination

PCV7

vaccination

Incremental

Hospitalised cases (n)

Total

83,430

73,845

-9,585

Paediatric

51,933

47,459

-4,474

Adult

31,497

26,386

-5,111

Deaths (n)

Total

1,074

666

-408

Paediatric

639

303

-336

Adult

435

363

-72

Life Years Lost (years)

Total

26,154.00

14,731.60

-11,422.50

Paediatric

19,482.60

9,239.90

-10,242.70

Adult

6,671.40

5,491.60

-1,179.80

Costs (RM million)

Total

255.8

657.9

402

Vaccine

0

439.6

439.6

Hospitalisation episodes

255.8

218.3

-37.5

   Paediatric

137.2

118.9

-18.3

   Adult

118.7

99.4

-19.3

ICER (per life year gained)

  

RM35,196

(US$10,261)